Iovance Biotherapeutics, Inc. (IOVA)
14.58
-0.04
(-0.31%)
USD |
NASDAQ |
Oct 12, 13:55
Iovance Biotherapeutics Net Income (TTM) : -289.52M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -289.52M |
| March 31, 2026 | -353.86M |
| December 31, 2025 | -390.98M |
| September 30, 2025 | -397.63M |
| June 30, 2025 | -389.92M |
| March 31, 2025 | -375.36M |
| December 31, 2024 | -372.18M |
| September 30, 2024 | -410.00M |
| June 30, 2024 | -440.22M |
| March 31, 2024 | -449.64M |
| December 31, 2023 | -444.04M |
| September 30, 2023 | -432.98M |
| June 30, 2023 | -418.84M |
| March 31, 2023 | -411.66M |
| December 31, 2022 | -395.89M |
| September 30, 2022 | -389.90M |
| June 30, 2022 | -376.41M |
| March 31, 2022 | -358.41M |
| December 31, 2021 | -342.25M |
| September 30, 2021 | -311.32M |
| June 30, 2021 | -283.77M |
| March 31, 2021 | -265.44M |
| December 31, 2020 | -259.58M |
| September 30, 2020 | -254.75M |
| June 30, 2020 | -245.67M |
| Date | Value |
|---|---|
| March 31, 2020 | -230.20M |
| December 31, 2019 | -197.56M |
| September 30, 2019 | -166.56M |
| June 30, 2019 | -150.91M |
| March 31, 2019 | -134.02M |
| December 31, 2018 | -123.58M |
| September 30, 2018 | -116.86M |
| June 30, 2018 | -105.18M |
| March 31, 2018 | -97.90M |
| December 31, 2017 | -92.06M |
| September 30, 2017 | -81.90M |
| June 30, 2017 | -78.51M |
| March 31, 2017 | -66.69M |
| December 31, 2016 | -52.89M |
| September 30, 2016 | -46.16M |
| June 30, 2016 | -35.04M |
| March 31, 2016 | -29.84M |
| December 31, 2015 | -28.26M |
| September 30, 2015 | -24.17M |
| June 30, 2015 | -19.33M |
| March 31, 2015 | -15.07M |
| December 31, 2014 | -12.03M |
| September 30, 2014 | -18.66M |
| June 30, 2014 | -25.28M |
| March 31, 2014 | -26.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AVITA Medical, Inc. | -43.08M |
| Halozyme Therapeutics, Inc. | 413.60M |
| Amgen, Inc. | 8.743B |
| CareDx, Inc. | 111.01M |
| Xencor, Inc. | -163.32M |